Back
Biomarin Pharmaceutical Stock Price Chart
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
BMRN
Biomarin Pharmaceutical
Last Price:
70.70
Seasonality Move:
5.7%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight selling pressure.
Biomarin Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.96 | Sell |
| 20-day SMA: | 83.55 | Sell |
| 50-day SMA: | 85.45 | Sell |
| 200-day SMA: | 86.8 | Sell |
| 8-day EMA: | 75.07 | Sell |
| 20-day EMA: | 80.72 | Sell |
| 50-day EMA: | 83.8 | Sell |
| 200-day EMA: | 85.86 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.4 | Sell |
| Relative Strength Index (14 RSI): | 22.78 | Sell |
| Chaikin Money Flow: | -1009919 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (77.4 - 92.98) | Sell |
| Bollinger Bands (100): | (78.06 - 88.38) | Sell |
Biomarin Pharmaceutical Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 70.69 while BMRN 8-day simple moving average is 75.96, which is a Sell signal.
- The stock price of BMRN is 70.69 while Biomarin Pharmaceutical 20-day SMA is 83.55, which makes it a Sell.
- Biomarin Pharmaceutical 50-day simple moving average is 85.45 while BMRN share price is 70.69, making it a Sell technically.
- BMRN stock price is 70.69 and Biomarin Pharmaceutical 200-day simple moving average is 86.80, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Sell
35
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a Sell
The current Biomarin Pharmaceutical [BMRN] share price is $70.69. The Score for BMRN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
13.46B
Price in USD:
70.69
Share Volume:
3.3M
Biomarin Pharmaceutical 52-Week Range
52-Week High:
99.56
52-Week Low:
68.83
Sell
35
Biomarin Pharmaceutical (BMRN)
is a Sell
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?
The Biomarin Pharmaceutical stock price is 70.69 USD today. -
Will BMRN stock go up or go down?
Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Biomarin Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 70.69 while BMRN 8-day exponential moving average is 75.07, which is a Sell signal.
- The stock price of BMRN is 70.69 while Biomarin Pharmaceutical 20-day EMA is 80.72, which makes it a Sell.
- Biomarin Pharmaceutical 50-day exponential moving average is 83.80 while BMRN share price is 70.69, making it a Sell technically.
- BMRN stock price is 70.69 and Biomarin Pharmaceutical 200-day simple moving average is 85.86, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
- BMRN Moving Average Covergence Divergence (MACD) indicator is -4.4, suggesting Biomarin Pharmaceutical is a Sell
- Biomarin Pharmaceutical Relative Strength Index (RSI) is 22.78, which suggest Biomarin Pharmaceutical is oversold
- The Bollinger Bands (25) for Biomarin Pharmaceutical is (77.4 - 92.98), which suggest Biomarin Pharmaceutical is a Sell
- The Bollinger Bands (100) for Biomarin Pharmaceutical is (78.06 - 88.38), which suggest Biomarin Pharmaceutical is a Sell
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.